PBH - CIK 0001295947
The table below shows Prestige Consumer Healthcare Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $79.01M | $54.78M | $48.09M | $58.25M | $69.31M | $75.15M |
| Capital expenditure | $838.00K | $1.15M | $1.48M | $1.05M | $1.50M | $2.55M |
| Investing cash flow | -$1.94M | -$2.13M | $2.32M | -$1.05M | -$1.32M | -$2.55M |
| Dividends paid | - | - | - | - | - |
Prestige Consumer Healthcare Inc. reported operating cash flow of $257.63M for fiscal year 2026. That is up 2.4% from $251.51M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $148.67M (FY 2017) to $257.63M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $34.77M | $25.98M | $25.00M | $37.73M | $0.00 | $0.00 |
| Financing cash flow | -$36.28M | -$65.52M | -$54.18M | -$47.37M | $63.65M | -$111.36M |